|
1
|
Shields CL, Furuta M, Thangappan A, Nagori
S, Mashayekhi A, Lally DR, Kelly CC, Rudich DS, Nagori AV, Wakade
OA, et al: Metastasis of uveal melanoma millimeter-by-millimeter in
8033 consecutive eyes. Arch Ophthalmol. 127:989–998.
2009.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Maranduca MA, Branisteanu D, Serban DN,
Branisteanu DC, Stoleriu G, Manolache N and Serban IL: Synthesis
and physiological implications of melanic pigments. Oncol Lett.
17:4183–4187. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Singh AD, Turell ME and Topham AK: Uveal
melanoma: Trends in incidence, treatment, and survival.
Ophthalmology. 118:1881–1885. 2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Virgili G, Gatta G, Ciccolallo L,
Capocaccia R, Biggeri A, Crocetti E, Lutz JM and Paci E: EUROCARE
Working Group. Incidence of uveal melanoma in Europe.
Ophthalmology. 114:2309–2315. 2007.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Hu DN, Yu GP, McCormick SA, Schneider S
and Finger PT: Population-based incidence of uveal melanoma in
various races and ethnic groups. Am J Ophthalmol. 140:612–617.
2005.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Tan LLY, Hong J, Goh WL, Chang EW, Yang
VS, Poon E, Somasundaram N, Farid M, Chan AS and Chan JY: Clinical
features and survival outcomes of ocular melanoma in a multi-ethnic
Asian cohort. Sci Rep. 10(16367)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Hammer H, Oláh J and Tóth-Molnár E:
Dysplastic nevi are a risk factor for uveal melanoma. Eur J
Ophthalmol. 6:472–474. 1996.PubMed/NCBI
|
|
8
|
Shields CL, Kaliki S, Livesey M, Walker B,
Garoon R, Bucci M, Feinstein E, Pesch A, Gonzalez C, Lally SE, et
al: Association of ocular and oculodermal melanocytosis with the
rate of uveal melanoma metastasis: Analysis of 7872 consecutive
eyes. JAMA Ophthalmol. 131:993–1003. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Shields CL, Furuta M, Berman EL, Zahler
JD, Hoberman DM, Dinh DH, Mashayekhi A and Shields JA: Choroidal
nevus transformation into melanoma: Analysis of 2514 consecutive
cases. Arch Ophthalmol. 127:981–987. 2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Shah CP, Weis E, Lajous M, Shields JA and
Shields CL: Intermittent and chronic ultraviolet light exposure and
uveal melanoma: A meta-analysis. Ophthalmology. 112:1599–1607.
2005.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Harbour JW, Onken MD, Roberson ED, Duan S,
Cao L, Worley LA, Council ML, Matatall KA, Helms C and Bowcock AM:
Frequent mutation of BAP1 in metastasizing uveal melanomas.
Science. 330:1410–1413. 2010.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Van Raamsdonk CD, Bezrookove V, Green G,
Bauer J, Gaugler L, O'Brien JM, Simpson EM, Barsh GS and Bastian
BC: Frequent somatic mutations of GNAQ in uveal melanoma and blue
naevi. Nature. 457:599–602. 2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Johansson P, Aoude LG, Wadt K, Glasson WJ,
Warrier SK, Hewitt AW, Kiilgaard JF, Heegaard S, Isaacs T,
Franchina M, et al: Deep sequencing of uveal melanoma identifies a
recurrent mutation in PLCB4. Oncotarget. 7:4624–4631.
2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Moore AR, Ceraudo E, Sher JJ, Guan Y,
Shoushtari AN, Chang MT, Zhang JQ, Walczak EG, Kazmi MA, Taylor BS,
et al: Recurrent activating mutations of G-protein-coupled receptor
CYSLTR2 in uveal melanoma. Nat Genet. 48:675–680. 2016.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Kilic E, Naus NC, van Gils W, Klaver CC,
van Til ME, Verbiest MM, Stijnen T, Mooy CM, Paridaens D, Beverloo
HB, et al: Concurrent loss of chromosome arm 1p and chromosome 3
predicts a decreased disease-free survival in uveal melanoma
patients. Invest Ophthalmol Vis Sci. 46:2253–2257. 2005.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Conway RM, Chua WC, Qureshi C and Billson
FA: Primary iris melanoma: Diagnostic features and outcome of
conservative surgical treatment. Br J Ophthalmol. 85:848–854.
2001.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kivelä T, Simpson RE and Grossniklaus HE:
Uveal melanoma. In: AJCC Cancer Staging Manual. 8th edition. Amin
B, Edge SB and Greene FL (eds). Springer, New York, NY, pp805-817,
2017.
|
|
18
|
Russo A, Avitabile T, Reibaldi M,
Bonfiglio V, Pignatelli F, Fallico M, Caltabiano R, Broggi G, Russo
D, Varricchio S, et al: Iris Melanoma: Management and prognosis.
Appl Sci. 10(8766)2020.
|
|
19
|
Kaliki S and Shields C: Uveal melanoma:
Relatively rare but deadly cancer. Eye (Lond). 31:241–257.
2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
No authors listed. Accuracy of diagnosis
of choroidal melanomas in the collaborative ocular melanoma study.
COMS report no. 1. Arch Ophthalmol. 108:1268–1273. 1990.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Finger PT: 7th Edition, AJCC-UICC
Ophthalmic Oncology Task Force. The 7th edition AJCC staging system
for eye cancer: An international language for ophthalmic oncology.
Arch Pathol Lab Med. 133:1197–1198. 2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Singh P and Singh A: Choroidal melanoma.
Oman J Ophthalmol. 5:3–9. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Onken MD, Worley LA, Char DH, Augsburger
JJ, Correa ZM, Nudleman E, Aaberg TM Jr, Altaweel MM, Bardenstein
DS, Finger PT, et al: Collaborative ocular oncology group report
number 1: Prospective validation of a multi-gene prognostic assay
in uveal melanoma. Ophthalmology. 119:1596–1603. 2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Onken MD, Worley LA, Tuscan MD and Harbour
JW: An accurate, clinically feasible multi-gene expression assay
for predicting metastasis in uveal melanoma. J Mol Diagn.
12:461–468. 2010.PubMed/NCBI View Article : Google Scholar
|
|
25
|
No authors listed. Histopathologic
characteristics of uveal melanomas in eyes enucleated from the
collaborative ocular melanoma study. COMS report no. 6. Am J
Ophthalmol. 125:745–766. 1998.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Shields CL, Manalac J, Das C, Ferguson K
and Shields JA: Choroidal melanoma: Clinical features,
classification, and top 10 pseudomelanomas. Curr Opin Ophthalmol.
25:177–185. 2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Diener-West M, Reynolds SM, Agugliaro DJ,
Caldwell R, Cumming K, Earle JD, Hawkins BS, Hayman JA, Jaiyesimi
I, Jampol LM, et al: Development of metastatic disease after
enrollment in the COMS trials for treatment of choroidal melanoma:
Collaborative ocular melanoma study group report No. 26. Arch
Ophthalmol. 123:1639–1643. 2005.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Krantz BA, Dave N, Komatsubara KM, Marr BP
and Carvajal RD: Uveal melanoma: Epidemiology, etiology, and
treatment of primary disease. Clin Ophthalmol. 11:279–289.
2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kaliki S, Shields CL and Shields JA: Uveal
melanoma: Estimating prognosis. Indian J Ophthalmol. 63:93–102.
2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Singh M, Durairaj P and Yeung J: Uveal
melanoma: A review of the literature. Oncol Ther. 6:87–104.
2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Territo C, Shields CL, Shields JA,
Augsburger JJ and Schroeder RP: Natural course of melanocytic
tumors of the iris. Ophthalmology. 95:1251–1255. 1988.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Shields CL, Kaliki S, Hutchinson A,
Nickerson S, Patel J, Kancherla S, Peshtani A, Nakhoda S, Kocher K,
Kolbus E, et al: Iris nevus growth into melanoma: Analysis of 1611
consecutive eyes: The ABCDEF guide. Ophthalmology. 120:766–772.
2013.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Sumich P, Mitchell P and Wang JJ:
Choroidal nevi in a white population: The blue mountains eye study.
Arch Ophthalmol. 116:645–650. 1998.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Singh AD, Kalyani P and Topham A:
Estimating the risk of malignant transformation of a choroidal
nevus. Ophthalmology. 112:1784–1789. 2005.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Shields CL, Cater J, Shields JA, Singh AD,
Santos MC and Carvalho C: Combination of clinical factors
predictive of growth of small choroidal melanocytic tumors. Arch
Ophthalmol. 118:360–364. 2000.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Damato BE, Heimann H, Kalirai H and
Coupland SE: Age, survival predictors, and metastatic death in
patients with choroidal melanoma: Tentative evidence of a
therapeutic effect on survival. JAMA Ophthalmol. 132:605–613.
2014.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Straatsma BR, Diener-West M, Caldwell R
and Engstrom RE: Collaborative Ocular Melanoma Study Group.
Mortality after deferral of treatment or no treatment for choroidal
melanoma. Am J Ophthalmol. 136:47–54. 2003.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Jager MJ, Shields CL, Cebulla CM,
Abdel-Rahman MH, Grossniklaus HE, Stern MH, Carvajal RD, Belfort
RN, Jia R, Shields JA and Damato BE: Uveal melanoma. Nat Rev Dis
Primers. 6(24)2020.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Singh AD, Rennie IG, Kivela T, Seregard S
and Grossniklaus H: The Zimmerman-McLean-Foster hypothesis: 25
years later. Br J Ophthalmol. 88:962–967. 2004.PubMed/NCBI View Article : Google Scholar
|
|
40
|
No authors listed. The collaborative
ocular melanoma study (COMS) randomized trial of pre-enucleation
radiation of large choroidal melanoma II: Initial mortality
findings. COMS report no. 10. Am J Ophthalmol. 125:779–796.
1998.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Collaborative Ocular Melanoma Study Group.
The COMS randomized trial of iodine 125 brachytherapy for choroidal
melanoma: V. Twelve-year mortality rates and prognostic factors:
COMS report No. 28. Arch Ophthalmol. 124:1684–1693. 2006.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Rospond-Kubiak I and Damato B: The
surgical approach to the management of anterior uveal melanomas.
Eye (Lond). 28:741–747. 2014.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Shields JA, Shields CL, Shah P and
Sivalingam V: Partial lamellar sclerouvectomy for ciliary body and
choroidal tumors. Ophthalmology. 98:971–983. 1991.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Caminal JM, Mejia K, Masuet-Aumatell C,
Arias L, Piulats JM, Gutierrez C, Pera J, Catala J, Rubio M and
Arruga J: Endoresection versus iodine-125 plaque brachytherapy for
the treatment of choroidal melanoma. Am J Ophthalmol.
156:334–342.e1. 2013.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Biewald E, Lautner H, Gök M, Horstmann GA,
Sauerwein W, Flühs D and Bornfeld N: Endoresection of large uveal
melanomas: Clinical results in a consecutive series of 200 cases.
Br J Ophthalmol. 101:204–208. 2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Süsskind D, Dürr C, Paulsen F, Kaulich T
and Bartz-Schmidt KU: Endoresection with adjuvant ruthenium
brachytherapy for selected uveal melanoma patients-the Tuebingen
experience. Acta Ophthalmol. 95:e727–e733. 2017.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Brewington BY, Shao YF, Davidorf FH and
Cebulla CM: Brachytherapy for patients with uveal melanoma:
Historical perspectives and future treatment directions. Clin
Ophthalmol. 12:925–934. 2018.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Dogrusöz M, Jager MJ and Damato B: Uveal
melanoma treatment and prognostication. Asia Pac J Ophthalmol
(Phila). 6:186–196. 2017.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Weis E, Salopek TG, McKinnon JG, Larocque
MP, Temple-Oberle C, Cheng T, McWhae J, Sloboda R and Shea-Budgell
M: Management of uveal melanoma: A consensus-based provincial
clinical practice guideline. Curr Oncol. 23:e57–e64.
2016.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Fallico M, Raciti G, Longo A, Reibaldi M,
Bonfiglio V, Russo A, Caltabiano R, Gattuso G, Falzone L and
Avitabile T: Current molecular and clinical insights into uveal
melanoma (review). Int J Oncol. 58(10)2021.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Chang MY and McCannel TA: Local treatment
failure after globe-conserving therapy for choroidal melanoma. Br J
Ophthalmol. 97:804–811. 2013.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Grange JD, Duquesne N, Roubeyrol F,
Branisteanu D, Sandon K, Fleury J, Gerard JP, Chauvel P, Pinzaru G,
Jean-Louis B and Bievelez B: Double irradiation for macroscopic
radioresistance or recurrence of melanomas of the posterior uvea:
Clinical, ballistic, therapeutic and prognostic aspects. Series of
19 cases among 462 patients. J Fr Ophtalmol. 22:1054–1063.
1999.PubMed/NCBI(In French).
|
|
53
|
Stålhammar G: Forty-year prognosis after
plaque brachytherapy of uveal melanoma. Sci Rep.
10(11297)2020.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Yupari R, Bena J, Wilkinson D, Suh J and
Singh A: Small choroidal melanoma: Outcomes following apical height
dose brachytherapy. Br J Ophthalmol. 105:1161–1165. 2021.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Detorakis ET, Engstrom RE, Wallace R and
Straatsma BR: Iris and anterior chamber angle neovascularization
after iodine 125 brachytherapy for uveal melanoma. Ophthalmology.
112:505–510. 2005.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Krema H, Somani S, Sahgal A, Xu W,
Heydarian M, Payne D, McGowan H, Michaels H, Simpson ER and
Laperriere N: Stereotactic radiotherapy for treatment of
juxtapapillary choroidal melanoma: 3-year follow-up. Br J
Ophthalmol. 93:1172–1176. 2009.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Fallico M, Chronopoulos A, Schutz JS and
Reibaldi M: Treatment of radiation maculopathy and
radiation-induced macular edema: A systematic review. Surv
Ophthalmol. 66:441–460. 2021.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Indaram M, Ali FS and Levin MH: In search
of a treatment for radiation-induced optic neuropathy. Curr Treat
Options Neurol. 17(325)2015.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Phillips C, Pope K, Hornby C, Chesson B,
Cramb J and Bressel M: Novel 3D conformal technique for treatment
of choroidal melanoma with external beam photon radiotherapy. J Med
Imaging Radiat Oncol. 57:230–236. 2013.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Verma V and Mehta MP: Clinical outcomes of
proton radiotherapy for uveal melanoma. Clin Oncol (R Coll Radiol).
28:e17–e27. 2016.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Gragoudas ES, Li W, Lane AM, Munzenrider J
and Egan KM: Risk factors for radiation maculopathy and
papillopathy after intraocular irradiation. Ophthalmology.
106:1571–1578. 1999.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Gragoudas ES: Proton beam irradiation of
uveal melanomas: The first 30 years. The weisenfeld lecture. Invest
Ophthalmol Vis Sci. 47:4666–4673. 2006.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Papakostas TD, Lane AM, Morrison M,
Gragoudas ES and Kim IK: Long-term outcomes after proton beam
irradiation in patients with large choroidal melanomas. JAMA
Ophthalmol. 135:1191–1196. 2017.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Parker T, Rigney G, Kallos J, Stefko ST,
Kano H, Niranjan A, Green AL, Aziz T, Rath P and Lunsford LD: Gamma
knife radiosurgery for uveal melanomas and metastases: A systematic
review and meta-analysis. Lancet Oncol. 21:1526–1536.
2020.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Meyer Schwickerath G and Vogel M:
Treatment of malignant melanomas of the choroid by
photocoagulation. Trans Ophthalmol Soc UK. 97:416–420.
1977.PubMed/NCBI
|
|
66
|
Foulds WS and Damato BE: Low-energy
long-exposure laser therapy in the management of choroidal
melanoma. Graefes Arch Clin Exp Ophthalmol. 224:26–31.
1986.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Mashayekhi A, Shields CL, Rishi P, Atalay
HT, Pellegrini M, McLaughlin JP, Patrick KA, Morton SJ, Remmer MH,
Parendo A, et al: Primary transpupillary thermotherapy for
choroidal melanoma in 391 cases: Importance of risk factors in
tumor control. Ophthalmology. 122:600–609. 2015.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Chojniak MM, Chojniak R, Nishimoto IN,
Allemann N and Erwenne CM: Primary transpupillary thermotherapy for
small choroidal melanoma. Graefes Arch Clin Exp Ophthalmol.
249:1859–1865. 2011.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Turkoglu EB, Pointdujour-Lim R, Mashayekhi
A and Shields CL: Photodynamic therapy as primary treatment for
small choroidal melanoma. Retina. 39:1319–1325. 2019.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Yordi S, Soto H, Bowen RC and Singh AD:
Photodynamic therapy for choroidal melanoma: What is the response
rate? Surv Ophthalmol. 66:552–559. 2021.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Diener-West M, Reynolds SM, Agugliaro DJ,
Caldwell R, Cumming K, Earle JD, Green DL, Hawkins BS, Hayman J,
Jaiyesimi I, et al: Screening for metastasis from choroidal
melanoma: the collaborative ocular melanoma study group report 23.
J Clin Oncol. 22:2438–2444. 2004.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Kujala E, Mäkitie T and Kivelä T: Very
long-term prognosis of patients with malignant uveal melanoma.
Invest Ophthalmol Vis Sci. 44:4651–4659. 2003.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Damato B, Eleuteri A, Taktak AF and
Coupland SE: Estimating prognosis for survival after treatment of
choroidal melanoma. Prog Retin Eye Res. 30:285–295. 2011.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Rebegea L, Firescu D, Baciu G and Ciubara
A: Psycho-oncology support. BRAIN. 10:77–88. 2019.
|
|
75
|
Pföhler C, Cree IA, Ugurel S, Kuwert C,
Haass N, Neuber K, Hengge U, Corrie PG, Zutt M, Tilgen W and
Reinhold U: Treosulfan and gemcitabine in metastatic uveal melanoma
patients: Results of a multicenter feasibility study. Anticancer
Drugs. 14:337–340. 2003.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Săftescu S, Popovici D, Oprean C, Negru A,
Croitoru A, Zemba M, Yasar I, Preda M and Negru Ș: Endurance of
erythrocyte series in chemotherapy. Exp Ther Med.
20(214)2020.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Nathan FE, Berd D, Sato T, Shield JA,
Shields CL, De Potter P and Mastrangelo MJ: BOLD+interferon in the
treatment of metastatic uveal melanoma: First report of active
systemic therapy. J Exp Clin Cancer Res. 16:201–208.
1997.PubMed/NCBI
|
|
78
|
Kirchberger MC, Moreira A, Erdmann M,
Schuler G and Heinzerling L: Real world experience in low-dose
ipilimumab in combination with PD-1 blockade in advanced melanoma
patients. Oncotarget. 9:28903–28909. 2018.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Pelster MS, Gruschkus SK, Bassett R,
Gombos DS, Shephard M, Posada L, Glover MS, Simien R, Diab A, Hwu
P, Carter BW and Patel SP: Nivolumab and ipilimumab in metastatic
uveal melanoma: Results from a single-arm phase II study. J Clin
Oncol. 39:599–607. 2021.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Buga A, Docea AO, Albu C, Malin RD,
Branisteanu DE, Ianosi G, Ianosi SL, Iordache A and Calina D:
Molecular and cellular stratagem of brain metastases associated
with melanoma (review). Oncol Lett. 17:4170–4175. 2019.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Radu A, Bejenaru C, Ţolea I, Maranduca MA,
Brănişteanu DC, Bejenaru LE, Petrariu FD, Stoleriu G and
Brănişteanu DE: Immunohistochemical study of CD117 in various
cutaneous melanocytic lesions. Exp Ther Med. 21(78)2021.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Najjar YG, Navrazhina K, Ding F, Bhatia R,
Tsai K, Abbate K, Durden B, Eroglu Z, Bhatia S, Park S, et al:
Ipilimumab plus nivolumab for patients with metastatic uveal
melanoma: A multicenter, retrospective study. J Immunother Cancer.
8(e000331)2020.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Carvajal RD, Schwartz GK, Tezel T, Marr B,
Francis JH and Nathan PD: Metastatic disease from uveal melanoma:
Treatment options and future prospects. Br J Ophthalmol. 101:38–44.
2017.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Piperno-Neumann S, Kapiteijn E, Larkin JM,
Carvajal RD, Luke JJ, Roozen HS, Zoubir M, Yang L, Choudhury S,
Yerramilli-Rao P, et al: Phase I dose-escalation study of the
protein kinase C (PKC) inhibitor AEB071 in patients with metastatic
uveal melanoma. J Clin Oncol. 32 (Suppl 15)(9030)2014.
|
|
85
|
Leyvraz S, Piperno-Neumann S, Suciu S,
Baurain JF, Zdzienicki M, Testori A, Marshall E, Scheulen M, Jouary
T, Negrier S, et al: Hepatic intra-arterial versus intravenous
fotemustine in patients with liver metastases from uveal melanoma
(EORTC 18021): A multicentric randomized trial. Ann Oncol.
25:742–746. 2014.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Mallone F, Sacchetti M, Lambiase A and
Moramarco A: Molecular insights and emerging strategies for
treatment of metastatic uveal melanoma. Cancers (Basel).
12(2761)2020.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Siegel R, Hauschild A, Kettelhack C,
Kähler KC, Bembenek A and Schlag PM: Hepatic arterial Fotemustine
chemotherapy in patients with liver metastases from cutaneous
melanoma is as effective as in ocular melanoma. Eur J Surg Oncol.
33:627–632. 2007.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Gonsalves CF, Eschelman DJ, Thornburg B,
Frangos A and Sato T: Uveal melanoma metastatic to the liver:
Chemoembolization with 1,3-Bis-(2-chloroethyl)-1-nitrosourea. AJR
Am J Roentgenol. 205:429–433. 2015.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Artzner C, Mossakowski O, Hefferman G,
Grosse U, Hoffmann R, Forschner A, Eigentler T, Syha R and
Grözinger G: Chemosaturation with percutaneous hepatic perfusion of
melphalan for liver-dominant metastatic uveal melanoma: A single
center experience. Cancer Imaging. 19(31)2019.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Mariani P, Piperno-Neumann S, Servois V,
Berry MG, Dorval T, Plancher C, Couturier J, Levy-Gabriel C,
Lumbroso-Le Rouic L, Desjardins L and Salmon RJ: Surgical
management of liver metastases from uveal melanoma: 16 years'
experience at the Institut Curie. Eur J Surg Oncol. 35:1192–1197.
2009.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Bale R, Schullian P, Schmuth M, Widmann G,
Jaschke W and Weinlich G: Stereotactic radiofrequency ablation for
metastatic melanoma to the liver. Cardiovasc Intervent Radiol.
39:1128–1135. 2016.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Gonsalves CF, Eschelman DJ, Adamo RD, Anne
PR, Orloff MM, Terai M, Hage AN, Yi M, Chervoneva I and Sato T: A
prospective phase II trial of radioembolization for treatment of
uveal melanoma hepatic metastasis. Radiology. 293:223–231.
2019.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Rodriguez-Vidal C, Fernandez-Diaz D,
Fernandez-Marta B, Lago-Baameiro N, Pardo M, Silva P, Paniagua L,
Blanco-Teijeiro MJ, Piñeiro A and Bande M: Treatment of metastatic
uveal melanoma: Systematic review. Cancers (Basel).
12(2557)2020.PubMed/NCBI View Article : Google Scholar
|
